{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T22:37:39Z","timestamp":1649198259197},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[1990,9,1]],"date-time":"1990-09-01T00:00:00Z","timestamp":652147200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[1990,9]]},"DOI":"10.1007\/bf03349598","type":"journal-article","created":{"date-parts":[[2014,4,9]],"date-time":"2014-04-09T03:04:55Z","timestamp":1397012695000},"page":"683-687","source":"Crossref","is-referenced-by-count":0,"title":["Resistance to a long-acting somatostatin analog (SMS 201-995) reversed by surgery in acromegaly"],"prefix":"10.1007","volume":"13","author":[{"given":"Roberto","family":"Attanasio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. G.","family":"Chiodini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Liuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Orlandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"De Palo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Dallabonzana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Lodrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Cozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,9]]},"reference":[{"key":"BF03349598_CR1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1210\/edrv-9-4-417","volume":"9","author":"SWJ Lamberts","year":"1988","unstructured":"Lamberts S.W.J. The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumors. Endocr. Rev. 9:417, 1988.","journal-title":"Endocr. Rev."},{"key":"BF03349598_CR2","volume-title":"70th Ann. Meet. Endocr. Soc., New Orleans, USA","author":"R Cozzi","year":"1988","unstructured":"Cozzi R., Chiodini P.G., Boccardi E., Dallabonzana D., Oppizzi G., De Palo C., Piolini M., Liuzzi A. Antitumoral effect of the long-term treatment of acromegaly with Sandostatin. 70th Ann. Meet. Endocr. Soc., New Orleans, USA, 1988, Abstract 114."},{"key":"BF03349598_CR3","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1210\/jcem-68-4-844","volume":"68","author":"JC Reubi","year":"1989","unstructured":"Reubi J.C., Landolt A.M. The growth hormone response to octreotide in acromegaly correlate with adenoma somatostatin receptor status. J. Clin. Endocrinol. Metab. 68: 844, 1989.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03349598_CR4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/jcem-60-1-48","volume":"60","author":"PG Chiodini","year":"1985","unstructured":"Chiodini P.G., Liuzzi A., Dallabonzana D., Oppizzi G., Verde G. Changes in growth hormone (GH) secretion induced by human pancreatic GH-releasing hormone-44 in acromegaly: a comparison with thyrotropin-releasing hormone and bromocriptine. J. Clin. Endocrinol. Metab. 60: 48, 1985.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03349598_CR5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1210\/endo-124-1-69","volume":"124","author":"N Kitajima","year":"1989","unstructured":"Kitajima N., Chihara K., Abe H., Okimura Y., Fujii Y., Sato M., Shakutsui S., Waranabe M., Fujita T. Effects of dopamine on immunoreactive growth hormone-releasing factor and somatostatin secretion from rat hypothalamic slices perfused in vitro. Endocrinology 124: 69, 1989.","journal-title":"Endocrinology"},{"key":"BF03349598_CR6","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0006-291X(84)90414-5","volume":"123","author":"T Paolo Di","year":"1984","unstructured":"Di Paolo T., Falardeau P. Dopamine receptors in rat pituitary and estradiol-induced pituitary tumors: effect of chronic treatment with bromocriptine. Biochem. Biophys. Res. Commun. 123: 312, 1984.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BF03349598_CR7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1210\/endo-117-1-217","volume":"117","author":"S Heisler","year":"1985","unstructured":"Heisler S., Srikant C.B. Somatostatin-14 and Somatostatin-28 pretreatment down-regulate somatostatin-14 receptors and have biphasic effects on forskolin-stimulated cyclic adenosine, 3\u2032-5\u2032-monophosphate synthesis and adrenocorticotropin secretion in mouse anterior pituitary tumor cells. Endocrinology 117: 217, 1985.","journal-title":"Endocrinology"},{"key":"BF03349598_CR8","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0021-9258(19)35411-0","volume":"263","author":"DH Presky","year":"1988","unstructured":"Presky D.H., Schonbrunn A. Somatostatin pretreatment increases the number of somatostatin receptors in GH4C1 pituitary cells and does not reduce cellular responsiveness to somatostatin. J. Biol. Chem. 263: 714, 1988.","journal-title":"J. Biol. Chem."},{"key":"BF03349598_CR9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1210\/jcem-65-1-65","volume":"65","author":"JC Reubi","year":"1987","unstructured":"Reubi J.C., Heitz P.U., Landolt A.M. Visualization of somatostatin receptors and correlation with immunoreactive growth hormone and prolactin in human pituitary adenomas: evidence for different tumor subclasses. J. Clin. Endocrinol. Metab. 65: 65, 1987.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03349598_CR10","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1210\/jcem-67-5-958","volume":"67","author":"M Kelijman","year":"1988","unstructured":"Kelijman M., Williams T.C., Downs T.R., Frohman L.A. Comparison of the sensitivity of growth hormone secretion to somatostatin in vivo and in vitro in acromegaly. J. Clin. Endocrinol. Metab. 67: 958, 1988.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03349598_CR11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1530\/acta.0.1130023","volume":"113","author":"DM Wilson","year":"1986","unstructured":"Wilson D.M., Hoffman A.R. Reduction of pituitary size by the somatostatin analogue SMS 201-995 in a patient with an islet cell tumor secreting growth hormone releasing factor. Acta. Endocrinol. (Copenh.) 113: 23, 1986.","journal-title":"Acta. Endocrinol. (Copenh.)"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03349598.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03349598\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03349598","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T04:09:18Z","timestamp":1648786158000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03349598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,9]]},"references-count":11,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1990,9]]}},"alternative-id":["BF03349598"],"URL":"https:\/\/doi.org\/10.1007\/bf03349598","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,9]]}}}